Morgan Stanley’s Tevogen Inc. Common Stock TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$78.3K Buy
17,334
+12,329
+246% +$151K ﹤0.01% 6254
2025
Q4
$82.9K Buy
5,005
+2,472
+98% +$64.3K ﹤0.01% 6270
2025
Q3
$99.5K Sell
2,533
-445
-15% -$21.9K ﹤0.01% 6155
2025
Q2
$186K Buy
2,978
+1,660
+126% +$94.6K ﹤0.01% 5882
2025
Q1
$71.2K Sell
1,318
-263
-17% -$17.3K ﹤0.01% 6157
2024
Q4
$81.4K Buy
1,581
+582
+58% +$37.9K ﹤0.01% 6135
2024
Q3
$18.4K Buy
999
+585
+141% +$17.1K ﹤0.01% 6531
2024
Q2
$15K Buy
+414
New +$27K ﹤0.01% 6546
2023
Q2
Hold
0
-$11 7707
2023
Q1
Hold
0
7659

Other funds holding TVGN

Morgan Stanley's TVGN Position: Q1 2026 in Review

Morgan Stanley increased its Tevogen Inc. Common Stock (TVGN) stake by 246% in Q1 2026, buying an estimated $151K and bringing the position to 17,334 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6254.

Morgan Stanley first reported a position in TVGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $186K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Morgan Stanley held 17,334 shares of Tevogen Inc. Common Stock worth $78.3K as of Q1 2026.
  • Morgan Stanley bought 12,329 Tevogen Inc. Common Stock shares in Q1 2026, an estimated $151K.
  • Tevogen Inc. Common Stock made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6254 holding.
  • Morgan Stanley first reported a position in Tevogen Inc. Common Stock in Q2 2024 and has held it in 8 quarters since.
  • Morgan Stanley's Tevogen Inc. Common Stock position peaked at $186K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.